Ache Laboratorios Farmaceuticos
São Paulo, Brazil· Est.
A leading Brazilian pharmaceutical company developing and commercializing prescription and OTC medicines across multiple therapeutic areas.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A leading Brazilian pharmaceutical company developing and commercializing prescription and OTC medicines across multiple therapeutic areas.
CardiovascularCentral Nervous SystemDermatologyGastroenterologyRespiratory
Technology Platform
The company utilizes a broad pharmaceutical development and manufacturing platform for small molecules and is developing capabilities in biologics and biosimilars.
Opportunities
Growth opportunities include expanding its biosimilar portfolio, leveraging its strong commercial footprint in Brazil to launch new products, and potential export growth within Latin America.
Risk Factors
Key risks include regulatory and pricing pressure from the Brazilian government's Unified Health System (SUS), economic instability in Brazil, and intense competition in the generics market.
Competitive Landscape
Aché competes with multinationals (e.g., Pfizer, Novartis) and large domestic Brazilian pharma companies. Its differentiation lies in its deep understanding of the local market, extensive manufacturing footprint, and strong portfolio of branded products.